Select a Sector or Industry
Long Term Debt Rankings for Drugs - Generic Industry
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Rank | Symbol | Company |
Long Term Debt
|
Pro Rating
|
|---|---|---|---|---|
| 1 | TBET | Tibet Pharmaceuticals | 0.00 | Go Pro |
| 1 | CPRX | Catalyst Pharmaceutical Partners | 0.00 | Go Pro |
| 1 | MYRX | Myrexis | 0.00 | Go Pro |
| 1 | AVNR | Avanir Pharmaceuticals | 0.00 | Go Pro |
| 1 | SGNT | Sagent Pharmaceuticals | 0.00 | Go Pro |
| 1 | SRLS | Seracare Life Sciences | 0.00 | Go Pro |
| 7 | HITK | Hi - Tech Pharmacal | 1.687M | Go Pro |
| 8 | LGND | LIGAND PHARMACEUTICALS | 35.65M | Go Pro |
| 9 | AKRX | Akorn | 101.74M | Go Pro |
| 10 | MRX | Medicis Pharmaceutical Corporation | 169.33M | Go Pro |
| 11 | PRX | Par Pharmaceutical Companies | 341.25M | Go Pro |
| 12 | SLXP | Salix Pharmaceuticals | 857.37M | Go Pro |
| 13 | WPI | Watson Pharmaceuticals | 1.353B | Go Pro |
| 14 | MYL | Mylan | 5.449B | Go Pro |
